Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 36 (RPL31P36) is a human pseudogene representing a nonfunctional, genomic copy of the functional ribosomal protein L31 gene (RPL31). Pseudogenes such as RPL31P36 do not encode active proteins and generally do not have biological activity or relevance as drug or therapeutic targets[4][5][8]. They are typically the result of gene duplication or retrotransposition events and exist throughout the genome as genetic relics. This gene is specifically described as a pseudogene in every reference, meaning it does not produce a functional protein and is not considered a viable drug target or therapeutic target[4][5][8]. No disease associations, biological functions, interacting drugs, or biomarker roles have been ascribed to this pseudogene. Its aliases mainly reference database accessions or alternative names for the pseudogene; none are linked to a functional protein[4][5]. If you are seeking information about therapeutic ribosomal proteins, refer to the parent gene RPL31 ("Ribosomal protein L31"), not its pseudogene derivatives[1][3]. The presence of many pseudogenes like RPL31P36 is typical among ribosomal protein families[1][8]. Most such pseudogenes are not transcribed or translated into functional proteins and do not play direct roles in disease or drug action. In summary, RPL31P36 is a nonfunctional genomic sequence, not an active target or receptor, and should not be considered in therapeutic targeting or biomarker development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 36 (RPL31P36).